![Bernd Winterhalter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernd Winterhalter
Corporate Officer/Principal at CureVac SE
Bernd Winterhalter active positions
Companies | Position | Start | End |
---|---|---|---|
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | 30/11/2019 | - |
Career history of Bernd Winterhalter
Former positions of Bernd Winterhalter
Companies | Position | Start | End |
---|---|---|---|
CUREVAC N.V. | Corporate Officer/Principal | 30/11/2019 | 31/01/2021 |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Chief Tech/Sci/R&D Officer | 31/12/2003 | 31/12/2017 |
Pharmacia GmbH | Chief Tech/Sci/R&D Officer | 31/12/1996 | 31/12/2002 |
Training of Bernd Winterhalter
University of Freiburg | Doctorate Degree |
Statistics
International
Germany | 6 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Private companies | 3 |
---|---|
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |
Pharmacia GmbH |
- Stock Market
- Insiders
- Bernd Winterhalter
- Experience